The Ecstasy and Agony of Assay Interference Compounds

ACS Chemical Biology

Volumn 12, Issue 3, 2017, Pages 575-578

  Aldrich, Courtney ^a   Bertozzi, Carolyn ^b   Georg, Gunda I ^g   Kiessling, Laura ^b   Lindsley, Craig ^c   Liotta, Dennis ^d   Merz, Kenneth M ^e   Schepartz, Alanna ^f   Wang, Shaomeng ^g  

^a ACS Infectious Diseases   (United States)

^b ACS Central Science   (United States)

^c ACS Chemical Biology   (United States)

^d ACS Chemical Neuroscience   (United States)

^e ACS Medicinal Chemistry Letters   (United States)

^f NY Medical College   (United States)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL COMPOUND; ENZYME INHIBITOR; COLLOID;

ASSAY; CONTROL SYSTEM; MOLECULE; PRIORITY JOURNAL; REVIEW; SCREENING; SPECTROSCOPY; ARTIFACT; CHEMISTRY; COLLOID; COMPUTER SIMULATION; DRUG DEVELOPMENT; HIGH THROUGHPUT SCREENING; PROCEDURES;

ARTIFACTS; COLLOIDS; COMPUTER SIMULATION; DRUG DISCOVERY; HIGH-THROUGHPUT SCREENING ASSAYS;

EID: 85015757146     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/acschembio.7b00119     Document Type: Review

References (42)

1. Baell, J. and Walters, M. A. (2014) Chemistry: Chemical con artists foil drug discovery Nature 513, 481-483 10.1038/513481a
2. McGovern, S. L., Caselli, E., Grigorieff, N., and Shoichet, B. K. (2002) A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening J. Med. Chem. 45, 1712-1722 10.1021/jm010533y
3. Allen, W. J., Yi, H. A., Gochin, M., Jacobs, A., and Rizzo, R. C. (2015) Small molecule inhibitors of HIVgp41 N-heptad repeat trimer formation Bioorg. Med. Chem. Lett. 25, 2853-2859 10.1016/j.bmcl.2015.04.067
4. Dong, X., Zhou, X., Jing, H., Chen, J., Liu, T., Yang, B., He, Q., and Hu, Y. (2011) Pharmacophore identification, virtual screening and biological evaluation of prenylated flavonoids derivatives as PKB/Akt1 inhibitors Eur. J. Med. Chem. 46, 5949-5958 10.1016/j.ejmech.2011.10.006
5. Zhong, Z., Liu, L. J., Dong, Z. Q., Lu, L., Wang, M., Leung, C. H., Ma, D. L., and Wang, Y. (2015) Structure-based discovery of an immunomodulatory inhibitor of TLR1-TLR2 heterodimerization from a natural product-like database Chem. Commun. (Cambridge, U. K.) 51, 11178-11181 10.1039/C5CC02728D
6. Mohammed, A., Al-Numair, K. S., and Balakrishnan, A. (2015) Docking studies on the interaction of flavonoids with fat mass and obesity associated protein Pak. J. Pharm. Sci. 28, 1647-1653
7. Park, H., Kim, S. Y., Kyung, A., Yoon, T. S., Ryu, S. E., and Jeong, D. G. (2012) Structure-based virtual screening approach to the discovery of novel PTPMT1 phosphatase inhibitors Bioorg. Med. Chem. Lett. 22, 1271-1275 10.1016/j.bmcl.2011.10.083
8. Brecher, M., Chen, H., Liu, B., Banavali, N. K., Jones, S. A., Zhang, J., Li, Z., Kramer, L. D., and Li, H. (2015) Novel broad spectrum inhibitors targeting the flavivirus methyltransferase PLoS One 10, e0130062 10.1371/journal.pone.0130062
9. Arrowsmith, C. H., Audia, J. E., Austin, C., Baell, J., Bennett, J., Blagg, J., Bountra, C., Brennan, P. E., Brown, P. J., Bunnage, M. E., Buser-Doepner, C., Campbell, R. M., Carter, A. J., Cohen, P., Copeland, R. A., Cravatt, B., Dahlin, J. L., Dhanak, D., Edwards, A. M., Frederiksen, M., Frye, S. V., Gray, N., Grimshaw, C. E., Hepworth, D., Howe, T., Huber, K. V., Jin, J., Knapp, S., Kotz, J. D., Kruger, R. G., Lowe, D., Mader, M. M., Marsden, B., Mueller-Fahrnow, A., Muller, S., O'Hagan, R. C., Overington, J. P., Owen, D. R., Rosenberg, S. H., Roth, B., Ross, R., Schapira, M., Schreiber, S. L., Shoichet, B., Sundstrom, M., Superti-Furga, G., Taunton, J., Toledo-Sherman, L., Walpole, C., Walters, M. A., Willson, T. M., Workman, P., Young, R. N., and Zuercher, W. J. (2015) The promise and peril of chemical probes Nat. Chem. Biol. 11, 536-541 10.1038/nchembio.1867
10. Baell, J. B. and Holloway, G. A. (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays J. Med. Chem. 53, 2719-2740 10.1021/jm901137j
11. Shoichet, B. K. (2006) Screening in a spirit haunted world Drug Discovery Today 11, 607-615 10.1016/j.drudis.2006.05.014
12. Walters, W. P. and Namchuk, M. (2003) Designing screens: how to make your hits a hit Nat. Rev. Drug Discovery 2, 259-266 10.1038/nrd1063
13. Rishton, G. M. (2003) Nonleadlikeness and leadlikeness in biochemical screening Drug Discovery Today 8, 86-96 10.1016/S1359644602025722
14. Simeonov, A., Jadhav, A., Thomas, C. J., Wang, Y., Huang, R., Southall, N. T., Shinn, P., Smith, J., Austin, C. P., Auld, D. S., and Inglese, J. (2008) Fluorescence spectroscopic profiling of compound libraries J. Med. Chem. 51, 2363-2371 10.1021/jm701301m
15. Lea, W. A. and Simeonov, A. (2011) Fluorescence polarization assays in small molecule screening Expert Opin. Drug Discovery 6, 17-32 10.1517/17460441.2011.537322
16. Thorne, N., Auld, D. S., and Inglese, J. (2010) Apparent activity in high-throughput screening: origins of compound-dependent assay interference Curr. Opin. Chem. Biol. 14, 315-324 10.1016/j.cbpa.2010.03.020
17. Ingolfsson, H. I., Thakur, P., Herold, K. F., Hobart, E. A., Ramsey, N. B., Periole, X., de Jong, D. H., Zwama, M., Yilmaz, D., Hall, K., Maretzky, T., Hemmings, H. C., Jr., Blobel, C., Marrink, S. J., Kocer, A., Sack, J. T., and Andersen, O. S. (2014) Phytochemicals perturb membranes and promiscuously alter protein function ACS Chem. Biol. 9, 1788-1798 10.1021/cb500086e
18. Schneider, C., Gordon, O. N., Edwards, R. L., and Luis, P. B. (2015) Degradation of curcumin: From mechanism to biological implications J. Agric. Food Chem. 63, 7606-7614 10.1021/acs.jafc.5b00244
19. Feng, B. Y., Shelat, A., Doman, T. N., Guy, R. K., and Shoichet, B. K. (2005) High-throughput assays for promiscuous inhibitors Nat. Chem. Biol. 1, 146-148 10.1038/nchembio718
20. Coan, K. E. and Shoichet, B. K. (2008) Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors J. Am. Chem. Soc. 130, 9606-9612 10.1021/ja802977h
21. Feng, B. Y., Simeonov, A., Jadhav, A., Babaoglu, K., Inglese, J., Shoichet, B. K., and Austin, C. P. (2007) A high-throughput screen for aggregation-based inhibition in a large compound library J. Med. Chem. 50, 2385-2390 10.1021/jm061317y
22. Jadhav, A., Ferreira, R. S., Klumpp, C., Mott, B. T., Austin, C. P., Inglese, J., Thomas, C. J., Maloney, D. J., Shoichet, B. K., and Simeonov, A. (2010) Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease J. Med. Chem. 53, 37-51 10.1021/jm901070c
23. Wolan, D. W., Zorn, J. A., Gray, D. C., and Wells, J. A. (2009) Small-molecule activators of a proenzyme Science 326, 853-858 10.1126/science.1177585
24. Bisson, J., McAlpine, J. B., Friesen, J. B., Chen, S. N., Graham, J., and Pauli, G. F. (2016) Can invalid bioactives undermine natural product-based drug discovery? J. Med. Chem. 59, 1671-1690 10.1021/acs.jmedchem.5b01009
25. Kilchmann, F., Marcaida, M. J., Kotak, S., Schick, T., Boss, S. D., Awale, M., Gönczy, P., and Reymond, J.-L. (2016) Discovery of a selective aurora a kinase inhibitor by virtual screening J. Med. Chem. 59, 7188-7211 10.1021/acs.jmedchem.6b00709
26. Thorne, N., Shen, M., Lea, W. A., Simeonov, A., Lovell, S., Auld, D. S., and Inglese, J. (2012) Firefly luciferase in chemical biology: a compendium of inhibitors, mechanistic evaluation of chemotypes, and suggested use as a reporter Chem. Biol. 19, 1060-1072 10.1016/j.chembiol.2012.07.015
27. Dahlin, J. L. and Walters, M. A. (2016) How to triage PAINS-full research Assay Drug Dev. Technol. 14, 168-174 10.1089/adt.2015.674
28. Baell, J. B. (2016) Feeling nature's PAINS: Natural products, natural product drugs, and pan assay interference compounds (PAINS) J. Nat. Prod. 79, 616-628 10.1021/acs.jnatprod.5b00947
29. Baell, J. B. (2010) Observations on screening-based research and some concerning trends in the literature Future Med. Chem. 2, 1529-1546 10.4155/fmc.10.237
30. Baell, J. B. (2015) Screening-based translation of public research encounters painful problems ACS Med. Chem. Lett. 6, 229-234 10.1021/acsmedchemlett.5b00032
31. Dahlin, J. L., Baell, J., and Walters, M. A. (2015) Assay interference by chemical reactivity, In Assay Guidance Manual (Sittampalam, G. S., Coussens, N. P., Nelson, H., Arkin, M., Auld, D., Austin, C., Bejcek, B., Glicksman, M., Inglese, J., Iversen, P. W., Li, Z., McGee, J., McManus, O., Minor, L., Napper, A., Peltier, J. M., Riss, T., Trask, O. J., Jr., and Weidner, J., Eds.) Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda, MD.
32. Ferreira, R. S., Bryant, C., Ang, K. K., McKerrow, J. H., Shoichet, B. K., and Renslo, A. R. (2009) Divergent modes of enzyme inhibition in a homologous structure-activity series J. Med. Chem. 52, 5005-5008 10.1021/jm9009229
33. Pouliot, M. and Jeanmart, S. (2016) Pan assay interference compounds (PAINS) and other promiscuous compounds in antifungal research J. Med. Chem. 59, 497-503 10.1021/acs.jmedchem.5b00361
34. Carlson, E. E., May, J. F., and Kiessling, L. L. (2006) Chemical probes of UDP-galactopyranose mutase Chem. Biol. 13, 825-837 10.1016/j.chembiol.2006.06.007
35. Yang, J. J., Ursu, O., Lipinski, C. A., Sklar, L. A., Oprea, T. I., and Bologa, C. G. (2016) Badapple: promiscuity patterns from noisy evidence J. Cheminf. 8, 29 10.1186/s13321-016-0137-3
36. Irwin, J. J., Duan, D., Torosyan, H., Doak, A. K., Ziebart, K. T., Sterling, T., Tumanian, G., and Shoichet, B. K. (2015) An aggregation advisor for ligand discovery J. Med. Chem. 58, 7076-7087 10.1021/acs.jmedchem.5b01105
37. Feng, B. Y. and Shoichet, B. K. (2006) A detergent-based assay for the detection of promiscuous inhibitors Nat. Protoc. 1, 550-553 10.1038/nprot.2006.77
38. Sassano, M. F., Doak, A. K., Roth, B. L., and Shoichet, B. K. (2013) Colloidal aggregation causes inhibition of G protein-coupled receptors J. Med. Chem. 56, 2406-2414 10.1021/jm301749y
39. Owen, S. C., Doak, A. K., Wassam, P., Shoichet, M. S., and Shoichet, B. K. (2012) Colloidal aggregation affects the efficacy of anticancer drugs in cell culture ACS Chem. Biol. 7, 1429-1435 10.1021/cb300189b
40. Babaoglu, K., Simeonov, A., Irwin, J., Nelson, M., Feng, B., Thomas, C., Cancian, L., Costi, M., Maltby, D., Jadhav, A., Inglese, J., Austin, C., and Shoichet, B. (2008) Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamase J. Med. Chem. 51, 2502-2511 10.1021/jm701500e
41. Shoichet, B. K. (2006) Interpreting steep dose-response curves in early inhibitor discovery J. Med. Chem. 49, 7274-7277 10.1021/jm061103g
42. Fallahi-Sichani, M., Honarnejad, S., Heiser, L. M., Gray, J. W., and Sorger, P. K. (2013) Metrics other than potency reveal systematic variation in responses to cancer drugs Nat. Chem. Biol. 9, 708-714 10.1038/nchembio.1337